drugset / Trial / NCT04014777
Study of NGM621 in Participants With Geographic Atrophy
Non-randomizedSequentialOpen-labelTreatment
Summary
This is a multi-center evaluation of NGM621 in an open-label, single-dose and multiple-dose escalation study in participants with Geographic Atrophy secondary to Age-related Macular Degeneration.
Timeline
- Start
- 2019-07-26
- Primary completion
- 2020-05-27
- Completion
- 2020-05-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NGM621 | Unknown | — | Intravitreal |